ID: MRFR/LS/5364-HCR | February 2021 | Region: Global | 90 pages
The global protein sequencing market is expected to grow significantly over the forecast period. The market held a market value of USD 892.5 million in 2017 and is projected to register a CAGR of 3.6% over the forecast period.
Protein sequencing are methods used for determining the amino acid sequence of proteins or peptides and for the analysis of the sequence. The rising focus on target-based drug development by biotechnology and pharmaceutical companies, growing financial support by the public and private sector for proteomic research, and advancements in clinical mass spectrometry and analytical techniques are some factors which are likely to drive the growth of the market during the forecast period. For instance, the National Cancer Institute Office of Cancer Clinical Proteomics Research provides funding opportunities for proteomics research. However, the high cost associated with infrastructure and instruments can hamper the market growth during the assessment period. For instance, the cost of mass spectrometers used in the study of proteomics is about USD 20,000.
Bioinformatics Solutions, Charles River Laboratories, Agilent Technologies, Inc., Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation are some of the key players in the global protein sequencing market.
The global protein sequencing market has been segmented into products and services, technology, application, and end user.
By products and services, the market has been segmented into reagent and consumables, instruments, analysis products/software, and protein sequencing services. The instrument segment has been further segmented into mass spectrometry instruments and Edman degradation sequencers. The reagents and consumables segment accounted for the largest share of the protein sequencing products market in 2017. The factors such as ongoing advancements in protein sequencing technologies and the rising number of sequencing procedures are expected to boost the growth of the segment.
On the basis of technology, the market has been segmented into mass spectrometry and Edman degradation.
On the basis of application, the market has been segmented into biotherapeutics, genetic engineering, and others. The biotherapeutics segment is anticipated to be the fastest growing segment during the forecast period.
The market, by end user, has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The protein sequencing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European protein sequencing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The protein sequencing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The protein sequencing market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global protein sequencing market owing to the rising application of protein sequencing in proteomic research, the development of protein sequencing, and availability of research funding in the region. For instance, in September 2016, the National Institute of Health (NIH) announced to fund for research on Proteomics, Immunoassay for TB Activation in HIV Patients.
Europe is expected to hold the second largest position in the global protein sequencing market. The market growth in this region is attributed to the increasing proteomics research and the availability of funding and infrastructure for research. For instance, PRIME-XS is a consortium of 12 European research institutes. It is a pan-European infrastructure for proteomics research.
The protein sequencing market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the increase in government funding for healthcare, rising R&D expenditure, and a growing number of biopharmaceutical companies.
The Middle East and Africa has the lowest share of the global protein sequencing market. Majority of the market of the region is anticipated to be held by the Middle Eastern region owing to the growing government initiatives for the healthcare sector.
Global Protein Sequencing Market Share (%), by Region, 2017
Source: White Papers, Company Presentations, Annual Reports
Global Protein Sequencing Market, by Products & Services
Global Protein Sequencing Market, by Technology
Global Protein Sequencing Market, by Application
Global Protein Sequencing Market, by End User
Global Protein Sequencing Market, by Region
The report for Global Protein Sequencing Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Frequently Asked Questions (FAQ) :
The protein sequencing market is projected to grow at a 3.6% CAGR between 2018-2023.
The Americas is projected to command the largest share in the protein sequencing market.
The biotherapeutics is likely to be the fastest growing application segment in the protein sequencing market.
Advancements in clinical mass spectrometry is boosting market growth.
High cost may limit market growth.